This research will help Artera understand how the test impacts cancer care decision-making so that it can be improved for patients in the future.

Any patient who is receiving a commercial ArteraAI Prostate Test and their ordering physician are eligible to participate if their clinic is an enrolling site. Patients may not be eligible for this study if patients do not have localized prostate cancer, or if patients have already begun or received treatment for their localized prostate cancer.

If you are a patient:
If your provider asks you to participate in the DIRECT-AI Registry, you will need to consent to Artera sending a brief survey to your treating doctor, which will ask about the utility of the ArteraAI Prostate Test. You will not have any responsibilities in the study.
This study is non-interventional, and does not require any additional procedures or tests. There will be no difference in the care you receive than if you decide not to participate.

If you are a physician:
If your clinic participates in the DIRECT-AI Registry, you will have the opportunity to enroll all patients for whom you order an ArteraAI Prostate Test in the study. As part of the study, you will complete a brief, 5-minute survey before and after receiving the test report, assessing your recommended treatment plan for each enrolled patient at that time point. This data will help evaluate the impact of the ArteraAI Prostate Test on shared decision-making between you and your patients.
Your primary responsibility in the study is completing these surveys. At the 1-year follow-up, Artera will contact your clinic’s research staff to collect the ultimate treatment received by the patient.

For participating patients, the study will last 1 year. Artera will collect information at 3 different timepoints: 

• Upon enrollment (e.g., consent, demographics, etc)
• Within 14 days of receiving the ArteraAI Prostate Test (physician survey)
• Treatment received at 1-year follow-up

Please fill out the form below or contact direct-ai@artera.ai if you have questions or are interested in participating.